Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NERVMinerva Neurosciences, Inc.

Nasdaq · CIK 0001598646
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts285

Identity from submissions API

NameMinerva Neurosciences, Inc.
CIK0001598646
TickersNERV
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN260784194
LEI—
Fiscal year end1231
State of incorporationMA MA
Phone617-600-7373
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1500 DISTRICT AVENUE
BURLINGTON
MA
01803
MA
Mailing address
1500 DISTRICT AVENUE
BURLINGTON
MA
01803
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

650 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 7.01,8.01,9.01 0001193125-26-462005 001-36517 261555336 34 8291962 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005051 005-88240 261555111 34 15411
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127420 005-88240 261554961 34 19576
2026-11-06 10-Q 10-Q 0001193125-26-451797 001-36517 261531745 34 9709985 1 1
2026-11-06 8-K 8-K 2.02,9.01 0001193125-26-450877 001-36517 261529624 34 237742 1 1
2026-11-03 4 xslF345X06/form4-11032026_111152.xml 0002095703-26-000008 6098
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003926 005-88240 261491764 34 10750
2026-08-20 3 xslF345X06/form3-08202026_080813.xml 0001610499-26-000004 18059
2026-08-20 3 xslF345X06/form3-08202026_080827.xml 0002149586-26-000002 18052
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003429 005-88240 261275824 34 15423
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000403 005-88240 261274953 34 47249
2026-08-12 8-K 8-K 5.02 0001193125-26-346817 001-36517 261267424 34 135260 1 1
2026-08-07 10-Q 10-Q 0001193125-26-339171 001-36517 261251410 34 9164478 1 1
2026-08-07 8-K 8-K 2.02,9.01 0001193125-26-339147 001-36517 261251392 34 239042 1 1
2026-08-03 4 xslF345X06/form4-08032026_100811.xml 0002095703-26-000006 6100
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001623632-26-000988 005-88240 261160778 34 46380
2026-06-05 4 xslF345X06/form4-06052026_060613.xml 0001405279-26-000002 5517
2026-06-05 4 xslF345X06/form4-06052026_060611.xml 0001610384-26-000002 5510
2026-06-05 4 xslF345X06/form4-06052026_060609.xml 0001642015-26-000002 5814
2026-06-05 4 xslF345X06/form4-06052026_060607.xml 0001642053-26-000002 5794
2026-06-05 4 xslF345X06/form4-06052026_060605.xml 0002095703-26-000004 5790
2026-06-05 4 xslF345X06/form4-06052026_060603.xml 0001021040-26-000002 5909
2026-06-05 4 xslF345X06/form4-06052026_060601.xml 0001226286-26-000002 5860
2026-06-04 8-K 8-K 3.03,5.03,5.07,9.01 0001193125-26-257379 001-36517 261064893 34 308590 1 1
2026-05-27 8-K 8-K 1.01,8.01,9.01 0001193125-26-241930 001-36517 261026418 34 435056 1 1
2026-05-27 424B5 424B5 0001193125-26-241915 333-294203 261026332 33 517338
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000130 005-88240 26984388 34 12313
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225087 005-88240 26981887 34 141857
2026-05-05 10-Q 10-Q 0001193125-26-205182 001-36517 26940687 34 7639768 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-205129 001-36517 26940536 34 250353 1 1
2026-04-23 ARS ARS 0001193125-26-171814 001-36517 26885508 34 615721
2026-04-23 DEFA14A DEFA14A 0001193125-26-171805 001-36517 26885495 34 1013522
2026-04-23 DEF 14A DEF 14A 0001193125-26-171799 001-36517 26885480 34 3098182 1 1
2026-04-22 4 xslF345X06/form4-04222026_080414.xml 0002129698-26-000004 5537
2026-04-22 3 xslF345X06/form3-04222026_080452.xml 0002129698-26-000002 8806
2026-04-10 PRE 14A PRE 14A 0001193125-26-150467 001-36517 26853355 34 3095705 1 1
2026-04-06 8-K 8-K 8.01 0001193125-26-143986 001-36517 26842067 34 133380 1 1
2026-04-02 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-26-140148 001-36517 26833691 34 519919 1 1
2026-04-01 4 xslF345X06/form4-04012026_040401.xml 0002095703-26-000002 6076
2026-03-31 144 xsl144X01/primary_doc.xml 0001623632-26-000481 001-36517 26823134 33 6153
2026-03-31 144 xsl144X01/primary_doc.xml 0001623632-26-000480 001-36517 26823083 33 6253
2026-03-31 144 xsl144X01/primary_doc.xml 0001623632-26-000479 001-36517 26823073 33 6235
2026-03-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000876 333-294203 26775980 33 1721
2026-03-17 CORRESP filename1.htm 0001193125-26-109862 7971
2026-03-16 UPLOAD filename1.pdf 0000000000-26-002667 333-294203 40025
2026-03-11 S-3 S-3 0001193125-26-101196 333-294203 26741735 33 1134670 1 1
2026-03-11 10-K 10-K 0001193125-26-101117 001-36517 26741578 34 11110201 1 1
2026-03-11 8-K 8-K 2.02,9.01 0001193125-26-101074 001-36517 26741523 34 285773 1 1
2026-03-10 144 xsl144X01/primary_doc.xml 0001623632-26-000411 001-36517 26740555 33 4814
2026-03-10 144 xsl144X01/primary_doc.xml 0001623632-26-000410 001-36517 26740496 33 4910
2026-03-10 144 xsl144X01/primary_doc.xml 0001623632-26-000409 001-36517 26740471 33 4900
2026-02-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-018125 005-88240 26659702 34 27677
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-26-000114 005-88240 26644122 34 27382
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-053133 005-88240 26636582 34 133946
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000891 005-88240 26623655 34 16972
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000044 005-88240 26602445 34 61639
2026-02-03 8-K 8-K 7.01,8.01 0001193125-26-034538 001-36517 26590287 34 140200 1 1
2026-01-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000082 333-292410 26513867 33 1721
2026-01-06 424B3 424B3 0001193125-26-004684 333-292410 26512469 33 233443
2026-01-02 CORRESP filename1.htm 0001193125-26-000413 7404
2025-12-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-127135 005-88240 251617723 34 26624
2025-12-31 UPLOAD filename1.pdf 0000000000-25-011919 333-292410 40121
2025-12-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-337075 005-88240 251614253 34 71045
2025-12-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000380 005-88240 251609129 34 57673
2025-12-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001623632-25-001804 005-88240 251603334 34 47415
2025-12-23 S-8 S-8 0001193125-25-331086 333-292422 251601407 33 210336 1 1
2025-12-23 4 xslF345X05/form4-12232025_041211.xml 0001642053-25-000004 12181
2025-12-23 4 xslF345X05/form4-12232025_041215.xml 0002095703-25-000007 5935
2025-12-23 4 xslF345X05/form4-12232025_041209.xml 0001226286-25-000003 12255
2025-12-23 4 xslF345X05/form4-12232025_041207.xml 0001642015-25-000004 12219
2025-12-23 4 xslF345X05/form4-12232025_041213.xml 0001021040-25-000004 12238
2025-12-23 4 xslF345X05/form4-12232025_041205.xml 0001405279-25-000004 11922
2025-12-23 4 xslF345X05/form4-12232025_041203.xml 0001610382-25-000004 11852
2025-12-23 4 xslF345X05/form4-12232025_041201.xml 0001610384-25-000005 11822
2025-12-23 S-3 S-3 0001193125-25-330849 333-292410 251600539 33 453950 1 1
2025-12-22 8-K 8-K 5.02,5.07,9.01 0001193125-25-328715 001-36517 251592441 34 334965 1 1
2025-11-24 ARS ARS 0001193125-25-293687 001-36517 251512990 34 561738
2025-11-24 DEF 14A DEF 14A 0001193125-25-293674 001-36517 251512950 34 3505864 1 1
2025-11-19 8-K 8-K 5.02,7.01,9.01 0001193125-25-287048 001-36517 251496693 34 238369 1 1
2025-11-18 4 xslF345X05/form4-11182025_091123.xml 0002095703-25-000005 5508
2025-11-18 3 xslF345X02/form3-11182025_091119.xml 0002095703-25-000002 10164
2025-11-14 PRE 14A PRE 14A 0001193125-25-283166 001-36517 251487345 34 3503862 1 1
2025-11-05 10-Q 10-Q 0001193125-25-265685 001-36517 251451692 34 5842482 1 1
2025-10-28 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001623632-25-001475 005-88240 251425442 34 66980
2025-10-22 8-K 8-K 1.01,3.02,5.03,7.01,9.01 0001193125-25-245552 001-36517 251408379 34 844288 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108840 001-36517 251218597 34 5060206 1 1
2025-05-13 10-Q 10-Q 0000950170-25-069780 001-36517 25937081 34 4672664 1 1
2025-04-29 10-K/A 10-K/A 0001193125-25-100977 001-36517 25882101 34 722656 1 1
2025-04-21 10-K/A 10-K/A 0001193125-25-087311 001-36517 25854051 34 623914 1 1
2025-03-19 8-K 8-K 8.01 0001193125-25-057901 001-36517 25753342 34 142511 1 1
2025-02-25 10-K 10-K 0000950170-25-026055 001-36517 25659221 34 8562298 1 1
2025-01-13 8-K 8-K 8.01 0001193125-25-005042 001-36517 25525019 34 141551 1 1
2024-12-06 4 xslF345X05/form4-12062024_051214.xml 0001415889-24-028544 6153
2024-12-06 4 xslF345X05/form4-12062024_051212.xml 0001415889-24-028543 6058
2024-12-06 4 xslF345X05/form4-12062024_051210.xml 0001415889-24-028542 6038
2024-12-06 4 xslF345X05/form4-12062024_051208.xml 0001415889-24-028541 6104
2024-12-06 4 xslF345X05/form4-12062024_051206.xml 0001415889-24-028540 5433
2024-12-06 4 xslF345X05/form4-12062024_051203.xml 0001415889-24-028539 5378
2024-12-06 4 xslF345X05/form4-12062024_051201.xml 0001415889-24-028538 5408
2024-12-05 8-K 8-K 5.07 0001193125-24-271652 001-36517 241529921 34 148818 1 1
2024-11-12 SC 13G/A filing.txt 0000315066-24-002831 005-88240 241444859 34 7816
2024-11-05 10-Q 10-Q 0000950170-24-121063 001-36517 241425576 34 4483832 1 1
2024-10-22 ARS ARS 0001193125-24-240736 001-36517 241384669 34 2682621
2024-10-22 DEFA14A DEFA14A 0001193125-24-240734 001-36517 241384666 34 935289
2024-10-22 DEF 14A DEF 14A 0001193125-24-240733 001-36517 241384659 34 1161319
2024-10-11 8-K 8-K 3.01 0001193125-24-236726 001-36517 241367673 34 141990 1 1
2024-09-16 8-K 8-K 8.01 0001193125-24-219590 001-36517 241301076 34 141897 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091195 001-36517 241177022 34 4060579 1 1
2024-05-30 8-K 8-K 5.02 0001193125-24-150357 001-36517 241005689 34 139712 1 1
2024-05-01 10-Q 10-Q 0000950170-24-050883 001-36517 24900008 34 3679551 1 1
2024-04-22 10-K/A 10-K/A 0001193125-24-105033 001-36517 24861941 34 606094 1 1
2024-04-12 8-K 8-K 3.01 0001193125-24-094620 001-36517 24841460 34 139864 1 1
2024-02-27 8-K 8-K 8.01,9.01 0001193125-24-047110 001-36517 24682055 34 167381 1 1
2024-02-26 10-K/A 10-K/A 0001193125-24-044724 001-36517 24672792 34 255119 1 1
2024-02-22 10-K 10-K 0000950170-24-018392 001-36517 24662198 34 7010231 1 1
2024-02-09 SC 13G filing.txt 0000315066-24-001300 005-88240 24611893 34 8178
2024-01-18 SC 13G/A nerv1573-form.htm 0001623632-24-000043 005-88240 24540426 34 432994
2023-11-07 10-Q 10-Q 0000950170-23-059747 001-36517 231381487 34 5261197 1 1
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052206 5377
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052205 5364
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052204 5401
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050828 6032
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050827 6065
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050826 5956
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050825 5966
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050824 5986
2023-09-28 8-K 8-K 5.07 0001193125-23-245615 001-36517 231289523 34 148573 1 1
2023-08-15 ARS ARS 0001193125-23-213105 001-36517 231173453 34 1910550
2023-08-15 DEFA14A DEFA14A 0001193125-23-213103 001-36517 231173448 34 692892
2023-08-15 DEF 14A DEF 14A 0001193125-23-213100 001-36517 231173442 34 1092515
2023-08-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-09 16:00:00 9999999995-23-002330 333-273686 231157000 33 1714
2023-08-09 424B3 424B3 0001193125-23-207506 333-273686 231156237 33 170606
2023-08-07 CORRESP filename1.htm 0001193125-23-205016 7238
2023-08-07 UPLOAD filename1.pdf 0000000000-23-008527 40220
2023-08-04 S-3 S-3 0001193125-23-203427 333-273686 231142243 33 250070
2023-08-01 10-Q 10-Q 0000950170-23-036159 001-36517 231129606 34 5146721 1 1
2023-07-07 SC 13D SC 13D 0001193125-23-183809 005-88240 231077000 34 99858
2023-07-07 3 FORM 3 SUBMISSION 0000899243-23-017269 7178
2023-07-03 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000043 021-485835 231065302 33 11942
2023-06-28 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-23-176877 001-36517 231049388 34 480531 1 1
2023-06-20 8-K 8-K 8.01 0001193125-23-169682 001-36517 231023512 34 140578 1 1
2023-06-02 8-K 8-K 3.01 0001193125-23-159827 001-36517 23988675 34 141466 1 1
2023-05-15 10-Q 10-Q 0000950170-23-021947 001-36517 23918329 34 4289240 1 1
2023-05-05 8-K 8-K 5.02 0001193125-23-137134 001-36517 23894122 34 140952 1 1
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026683 9910
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026681 7391
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026678 7427
2023-05-01 8-K 8-K 8.01,9.01 0001193125-23-128726 001-36517 23869987 34 162661 1 1
2023-04-20 10-K/A 10-K/A 0001193125-23-108431 001-36517 23833803 34 936119 1 1
2023-03-08 10-K 10-K 0000950170-23-006577 001-36517 23714820 34 8539718 1 1
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-23-000371 005-88240 23628783 34 39520
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016486 005-88240 23603757 34 12970
2023-02-01 SC 13G/A form824.htm 0001623632-23-000224 005-88240 23575377 34 212900
2022-12-28 8-K 8-K 8.01,9.01 0001193125-22-313129 001-36517 221491665 34 160320 1 1
2022-12-16 8-K 8-K 5.02,9.01 0001193125-22-307381 001-36517 221468398 34 155841 1 1
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061239 5344
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061238 5334
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061237 5371
2022-12-02 8-K 8-K 3.01 0001193125-22-297518 001-36517 221441899 34 139960 1 1
2022-11-09 10-Q 10-Q 0000950170-22-023496 001-36517 221370600 34 5040439 1 1
2022-10-17 8-K 8-K 8.01,9.01 0001193125-22-263403 001-36517 221312621 34 161239 1 1
2022-09-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-23 16:00:00 9999999995-22-002815 333-267424 221263522 33 1714
2022-09-21 UPLOAD filename1.pdf 0000000000-22-010392 40188
2022-09-21 CORRESP filename1.htm 0001193125-22-248406 7237
2022-09-21 UPLOAD filename1.pdf 0000000000-22-010366 39639
2022-09-14 S-3 S-3 0001193125-22-244838 333-267424 221243770 33 1429998
2022-09-14 CORRESP filename1.htm 0001193125-22-244592 12940
2022-09-12 UPLOAD filename1.pdf 0000000000-22-009918 44050
2022-09-09 8-K 8-K 3.01,9.01 0001193125-22-242001 001-36517 221236503 34 159210 1 1
2022-08-23 SC 13G SCHEDULE 13G 0000899140-22-000654 005-88240 221188003 34 46897
2022-08-22 8-K 8-K 8.01,9.01 0001193125-22-226016 001-36517 221182258 34 182233 1 1
2022-08-16 4 PRIMARY DOCUMENT 0000312069-22-000109 4032
2022-08-10 3 PRIMARY DOCUMENT 0000312069-22-000098 5393
2022-08-09 10-Q 10-Q 0000950170-22-015754 001-36517 221146412 34 4666742 1 1
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039689 6326
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039688 6190
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039686 6402
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039685 6435
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039684 6336
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039683 6356
2022-06-17 8-K 8-K 5.03,9.01 0001193125-22-176540 001-36517 221024251 34 171256 1 1
2022-06-15 8-K 8-K 5.07 0001193125-22-174803 001-36517 221018146 34 162258 1 1
2022-05-04 10-Q 10-Q 0001564590-22-017670 001-36517 22889836 34 3670497 1 1
2022-04-26 DEFA14A DEFA14A 0001193125-22-120341 001-36517 22854860 34 225540
2022-04-26 DEF 14A DEF 14A 0001193125-22-120328 001-36517 22854816 34 1038391
2022-04-14 PRE 14A PRE 14A 0001193125-22-105549 001-36517 22827314 34 1038398
2022-04-13 8-K 8-K 7.01,9.01 0001193125-22-103843 001-36517 22823995 34 5323234 1 1
2022-04-07 8-K 8-K 8.01,9.01 0001193125-22-098270 001-36517 22812389 34 180515 1 1
2022-03-14 8-K 8-K 3.01 0001193125-22-074127 001-36517 22735162 34 146209 1 1
2022-03-01 10-K 10-K 0001564590-22-007853 001-36517 22693829 34 8276779 1 1
2022-02-28 8-K 8-K 8.01,9.01 0001193125-22-056251 001-36517 22684346 34 169667 1 1
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011313 5360
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011304 5342
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011299 5352
2022-02-14 SC 13G/A form62.htm 0001623632-22-000241 005-88240 22629130 34 278113
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-035974 005-88240 22617023 34 34579
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018105 005-88240 22610344 34 12970
2022-01-18 8-K 8-K 3.01 0001193125-22-010710 001-36517 22533812 34 147214 1 1
2022-01-05 8-K 8-K 7.01,9.01 0001193125-22-002261 001-36517 22509480 34 7069055 1 1
2021-12-08 8-K 8-K 7.01,9.01 0001193125-21-351399 001-36517 211478721 34 4778140 1 1
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067938 5709
2021-11-24 SC 13G UNTERSCHREITUNG 0001546007-21-000007 005-88240 211441379 34 8679
2021-11-24 SC 13G UEBERSCHREITUNG 0001546007-21-000006 005-88240 211441372 34 8656
2021-11-08 10-Q 10-Q 0001564590-21-055049 001-36517 211386473 34 5620122 1 1
2021-11-03 8-K 8-K 8.01,9.01 0001193125-21-317782 001-36517 211373861 34 165135 1 1
2021-10-12 8-K 8-K 5.02,9.01 0001193125-21-296143 001-36517 211316644 34 329717 1 1
2021-09-30 8-K 8-K 8.01,9.01 0001193125-21-287430 001-36517 211293792 34 254693 1 1
2021-09-08 8-K 8-K 5.02,9.01 0001193125-21-267364 001-36517 211240818 34 278251 1 1
2021-08-09 SC TO-I/A SC TO-I/A 0001193125-21-239910 005-88240 211154743 34 24282
2021-08-02 SC TO-I/A SC TO-I/A 0001193125-21-232490 005-88240 211134907 34 283021
2021-08-02 10-Q 10-Q 0001564590-21-039633 001-36517 211134712 34 5161261 1 1
2021-07-12 SC 13G/A us6033801068_071021.txt 0000834237-21-008789 005-88240 211084478 34 12165
2021-07-06 SC TO-I SC TO-I 0001193125-21-208736 005-88240 211074222 34 402835
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-040932 6000
2021-06-16 8-K 8-K 5.07 0001193125-21-192109 001-36517 211021547 34 158668 1 1
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040687 5775
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040683 6033
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040680 5924
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040675 5954
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040673 5934
2021-05-12 10-Q 10-Q 0001564590-21-026731 001-36517 21913418 34 4435365 1 1
2021-04-30 DEFA14A DEFA14A 0001193125-21-145266 001-36517 21878713 34 1068536
2021-04-30 DEF 14A DEF 14A 0001193125-21-145239 001-36517 21878650 34 736582
2021-04-20 PRE 14A PRE 14A 0001193125-21-122824 001-36517 21838023 34 735994
2021-04-19 8-K 8-K 5.02 0001193125-21-121256 001-36517 21834792 34 151173 1 1
2021-03-08 10-K 10-K 0001564590-21-011340 001-36517 21720557 34 9531721 1 1
2021-02-16 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-21-002352 005-88240 21631723 34 56150
2021-02-12 SC 13G/A formminerva.htm 0001623632-21-000217 005-88240 21624936 34 437524
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019614 005-88240 21612885 34 13840
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-018641 005-88240 21611396 34 13810
2021-02-08 SC 13G/A filing.txt 0000315066-21-001135 005-88240 21599686 34 8408
2021-01-29 SC 13G/A us6033801068_012921.txt 0000834237-21-004702 005-88240 21572725 34 13105
2021-01-19 8-K 8-K 1.01,9.01 0001193125-21-010858 001-36517 21533975 34 173750 1 1
2020-12-16 4 FORM 4 SUBMISSION 0001209191-20-063926 9001
2020-12-16 4 FORM 4 SUBMISSION 0001209191-20-063924 8979
2020-12-16 4 FORM 4 SUBMISSION 0001209191-20-063923 9681
2020-12-16 4 FORM 4 SUBMISSION 0001209191-20-063922 9009
2020-12-01 8-K 8-K 8.01,9.01 0001193125-20-306138 001-36517 201359709 34 188679 1 1
2020-11-02 10-Q 10-Q 0001564590-20-049430 001-36517 201278945 34 6182335 1 1
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054807 5353
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054806 5339
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054805 5340
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054804 5356
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054803 5363
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054801 5371
2020-10-14 4 FORM 4 SUBMISSION 0001209191-20-054800 5344
2020-10-14 8-K 8-K 5.02 0001193125-20-269392 001-36517 201239507 34 153991 1 1
2020-09-11 4 FORM 4 SUBMISSION 0001209191-20-050176 4595
2020-09-08 8-K 8-K 8.01 0001193125-20-240512 001-36517 201162941 34 148276 1 1
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046957 5652
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046954 5640
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046953 5648
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046952 5662
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046950 5635
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046949 5636
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046948 5655
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046947 5670
2020-08-07 S-8 S-8 0001193125-20-213669 333-242460 201086447 33 54156
2020-08-03 10-Q 10-Q 0001564590-20-035289 001-36517 201067786 34 6616551 1 1
2020-07-02 8-K 8-K 5.02 0001193125-20-186864 001-36517 201009694 34 17558
2020-07-01 8-K 8-K 1.01,1.02,8.01,9.01 0001193125-20-185290 001-36517 201005992 34 31653
2020-06-25 8-K 8-K 5.07 0001193125-20-179182 001-36517 20990130 34 29105
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036342 6032
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036339 5953
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036337 5933
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036336 5924
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036335 5999
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036331 6001
2020-06-05 8-K 8-K 8.01,9.01 0001193125-20-162243 001-36517 20946700 34 7474392
2020-05-29 8-K 8-K 8.01,9.01 0001193125-20-155824 001-36517 20928252 34 110163
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032322 4801
2020-05-04 10-Q 10-Q 0001564590-20-020617 001-36517 20842724 34 4670966 1
2020-04-28 DEFA14A DEFA14A 0001193125-20-121801 001-36517 20822163 34 455104
2020-04-28 DEF 14A DEF 14A 0001193125-20-121740 001-36517 20822149 34 812946
2020-04-01 8-K 8-K 7.01,9.01 0001193125-20-094671 001-36517 20765755 34 7915395
2020-03-13 8-K 8-K 8.01,9.01 0001193125-20-071900 001-36517 20710532 34 33096
2020-03-09 8-K 8-K 8.01,9.01 0001193125-20-066371 001-36517 20696657 34 85138
2020-03-09 10-K 10-K 0001564590-20-009243 001-36517 20696471 34 8323175 1
2020-02-14 SC 13G/A form.htm 0001623632-20-000262 005-88240 20617567 34 280387
2020-02-12 SC 13G/A AMENDED SC 13G 0001387131-20-001446 005-88240 20605563 34 53121
2020-02-07 SC 13G/A filing.txt 0000315066-20-001092 005-88240 20585768 34 8307
2020-02-05 SC 13G/A us6033801068_020520.txt 0000834237-20-006012 005-88240 20577808 34 13105
2020-02-05 8-K 8-K 8.01,9.01 0001193125-20-024917 001-36517 20576437 34 28501
2020-01-06 8-K 8-K 8.01,9.01 0001193125-20-002240 001-36517 20510464 34 27161
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001129 5359
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001125 5347
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001119 5355
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001116 5369
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001114 5342
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001107 5343
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001103 5362
2020-01-03 4 FORM 4 SUBMISSION 0001209191-20-001096 5377
2019-12-18 8-K 8-K 8.01,9.01 0001193125-19-317563 001-36517 191292824 34 32997
2019-12-17 4 FORM 4 SUBMISSION 0001209191-19-060890 8983
2019-12-17 4 FORM 4 SUBMISSION 0001209191-19-060887 9685
2019-12-17 4 FORM 4 SUBMISSION 0001209191-19-060886 9012
2019-12-17 4 FORM 4 SUBMISSION 0001209191-19-060885 9004
2019-12-13 4 FORM 4 SUBMISSION 0001209191-19-060350 4735
2019-12-10 SC 13G/A minervaform.htm 0001623632-19-001689 005-88240 191276627 34 280207
2019-11-04 10-Q 10-Q 0001564590-19-039496 001-36517 191188225 34 6024484 1
2019-10-01 8-K 8-K 8.01,9.01 0001193125-19-259276 001-36517 191127561 34 33802
2019-09-24 8-K 8-K 1.01,9.01 0001193125-19-253569 001-36517 191110858 34 39094
2019-08-05 10-Q 10-Q 0001564590-19-028509 001-36517 19997525 34 5558448 1
2019-07-01 4 FORM 4 SUBMISSION 0001209191-19-039748 4337
2019-06-27 4 FORM 4 SUBMISSION 0001209191-19-039271 4595
2019-06-27 4 FORM 4 SUBMISSION 0001209191-19-039270 4485
2019-06-27 4 FORM 4 SUBMISSION 0001209191-19-039268 4562
2019-06-27 4 FORM 4 SUBMISSION 0001209191-19-039266 5731
2019-06-26 4 FORM 4 SUBMISSION 0000899243-19-018204 13104
2019-06-26 8-K 8-K 8.01,9.01 0001193125-19-181947 001-36517 19920008 34 70742
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017798 16185
2019-06-19 4 FORM 4 SUBMISSION 0000899243-19-017418 16190
2019-06-18 SC 13D/A SC 13D/A 0001193125-19-175712 005-88240 19904066 34 305093
2019-06-17 4 FORM 4 SUBMISSION 0000899243-19-017189 16186
2019-06-13 4 FORM 4 SUBMISSION 0000899243-19-016830 16183
2019-06-13 4 FORM 4 SUBMISSION 0001209191-19-036792 5424
2019-06-03 8-K 8-K 5.07 0001193125-19-163015 001-36517 19871586 34 22073
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033707 5680
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033706 5601
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033705 5581
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033704 5647
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033703 5423
2019-05-31 4 FORM 4 SUBMISSION 0001209191-19-033702 5572
2019-05-21 4 FORM 4 SUBMISSION 0000899243-19-014268 15650
2019-05-16 4 FORM 4 SUBMISSION 0000899243-19-013815 19284
2019-05-16 8-K 8-K 8.01,9.01 0001193125-19-148632 001-36517 19830614 34 54701
2019-05-06 10-Q 10-Q 0001564590-19-015804 001-36517 19798041 34 5376681 1
2019-04-17 DEFA14A DEFA14A 0001193125-19-108372 001-36517 19752193 34 56708
2019-04-17 DEF 14A DEF 14A 0001193125-19-108366 001-36517 19752190 34 327847
2019-04-11 RW RW 0001193125-19-103875 333-203737 19743963 NE 36700
2019-03-12 10-K 10-K 0001564590-19-007246 001-36517 19673899 34 8575562 1
2019-02-14 SC 13G SC 13G 0001193125-19-040872 005-88240 19606576 34 37620
2019-02-13 SC 13G/A form.htm 0001623632-19-000246 005-88240 19596712 34 361889
2019-02-13 SC 13G/A filing.txt 0000315066-19-001200 005-88240 19594959 34 8309
2019-02-08 SC 13G us6033801068_020719.txt 0000215457-19-006806 005-88240 19576614 34 13144
2018-12-26 4 FORM 4 SUBMISSION 0001209191-18-064104 4338
2018-12-18 4 FORM 4 SUBMISSION 0001209191-18-063195 8983
2018-12-18 4 FORM 4 SUBMISSION 0001209191-18-063191 9013
2018-12-18 4 FORM 4 SUBMISSION 0001209191-18-063187 9685
2018-12-18 4 FORM 4 SUBMISSION 0001209191-18-063183 9005
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062467 5363
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062465 5348
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062464 7105
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062463 5369
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062462 5346
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062461 5347
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062459 5366
2018-12-13 4 FORM 4 SUBMISSION 0001209191-18-062458 5381
2018-12-12 4 FORM 4 SUBMISSION 0001209191-18-062261 9461
2018-11-21 4 FORM 4 SUBMISSION 0001209191-18-059709 4338
2018-11-05 10-Q 10-Q 0001564590-18-026620 001-36517 181158711 34 4694794 1
2018-10-15 4 FORM 4 SUBMISSION 0001209191-18-054978 4343
2018-10-05 SC 13D/A SC 13D/A: AMENDMENT NO. 3 0001193125-18-294591 005-88240 181110434 34 255621
2018-10-03 4 FORM 4 SUBMISSION 0001209191-18-053871 14861
2018-10-03 4 FORM 4 SUBMISSION 0000899243-18-025985 13130
2018-10-01 4 FORM 4 SUBMISSION 0000899243-18-025642 16200
2018-09-19 4 FORM 4 SUBMISSION 0001209191-18-051657 4344
2018-09-17 4 FORM 4 SUBMISSION 0001209191-18-051204 5867
2018-09-11 4 FORM 4 SUBMISSION 0001209191-18-050573 6667
2018-08-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-08-24 16:00:00 9999999995-18-002198 333-226783 181038035 33 1714
2018-08-24 4 FORM 4 SUBMISSION 0001209191-18-048366 8671
2018-08-22 CORRESP filename1.htm 0001193125-18-255093 5658
2018-08-20 UPLOAD filename1.pdf 0000000000-18-025681 44837
2018-08-10 S-3 FORM S-3 0001193125-18-246082 333-226783 181009146 33 1262526
2018-08-02 4 FORM 4 SUBMISSION 0001209191-18-045008 5104
2018-08-02 4 FORM 4 SUBMISSION 0001209191-18-045007 5388
2018-08-02 3 FORM 3 SUBMISSION 0001209191-18-045006 6584
2018-08-02 10-Q 10-Q 0001564590-18-018659 001-36517 18986606 34 4765092 1
2018-07-17 4 FORM 4 SUBMISSION 0001209191-18-042871 5409
2018-07-17 3 FORM 3 SUBMISSION 0001209191-18-042870 6473
2018-07-17 8-K FORM 8-K 5.02,9.01 0001193125-18-219720 001-36517 18956787 34 27984
2018-06-15 S-8 S-8 0001193125-18-194554 333-225672 18902605 33 55719
2018-06-11 4 FORM 4 SUBMISSION 0001209191-18-036991 9213
2018-06-11 4 FORM 4 SUBMISSION 0001209191-18-036986 9154
2018-06-11 4 FORM 4 SUBMISSION 0001209191-18-036979 9118
2018-06-11 4 FORM 4 SUBMISSION 0001209191-18-036972 5653
2018-06-11 4 FORM 4 SUBMISSION 0001209191-18-036966 5428
2018-06-11 8-K FORM 8-K 5.02,5.07,9.01 0001193125-18-189474 001-36517 18892338 34 118331
2018-05-03 10-Q 10-Q 0001564590-18-010484 001-36517 18801749 34 4510344 1
2018-04-24 DEFA14A DEFA14A 0001193125-18-127655 001-36517 18770082 34 77724
2018-04-24 DEF 14A DEF 14A 0001193125-18-127648 001-36517 18770073 34 505423
2018-03-22 8-K 8-K 8.01,9.01 0001193125-18-091355 001-36517 18705702 34 11202881
2018-03-12 S-8 S-8 0001193125-18-079294 333-223593 18683793 33 52994
2018-03-12 10-K 10-K 0001564590-18-005224 001-36517 18681949 34 9902417 1
2018-03-08 SC 13G/A us6033801068_030518.txt 0000215457-18-005425 005-88240 18676369 34 12221
2018-02-21 8-K 8-K 8.01,9.01 0001193125-18-051083 001-36517 18627009 34 11737219
2018-02-14 SC 13G/A SC 13G/A 0001193125-18-045863 005-88240 18613549 34 140522
2018-02-14 SC 13G/A sc13ga.htm 0000929638-18-000282 005-88240 18612254 34 103004
2018-02-14 SC 13G/A form.htm 0001623632-18-000219 005-88240 18610270 34 276145
2018-02-13 SC 13G/A filing.txt 0000315066-18-001417 005-88240 18599961 34 9437
2018-02-05 8-K FORM 8-K 5.02,8.01,9.01 0001193125-18-031567 001-36517 18572863 34 26711
2018-02-02 4 FORM 4 SUBMISSION 0001209191-18-007242 26878
2018-02-01 SC 13G us6033801068_013118.txt 0000215457-18-004494 005-88240 18564944 34 13096
2018-01-08 8-K 8-K 8.01,9.01 0001193125-18-005144 001-36517 18514948 34 2083310
2018-01-04 4 FORM 4 SUBMISSION 0001209191-18-001965 5371
2017-12-29 S-8 S-8 0001193125-17-383595 333-222368 171282283 33 77657
2017-12-15 4 FORM 4 SUBMISSION 0001209191-17-065970 16413
2017-12-15 4 FORM 4 SUBMISSION 0001209191-17-065967 15200
2017-12-15 4 FORM 4 SUBMISSION 0001209191-17-065962 15252
2017-12-15 4 FORM 4 SUBMISSION 0001209191-17-065958 8974

Latest XBRL company facts

One latest value per concept from companyfacts (285 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.84M 2026-11-03 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
dei EntityPublicFloat Entity Public Float USD 7.00M 2025-06-30 2025 FY 10-K 2026-03-11 0001193125-26-101117
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.60M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171799
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 4.38M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171799
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 9.86M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171799
ecd PeoTotalCompAmt PeoTotalCompAmt USD 9.35M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171799
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 252.83 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171799
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.77M 2015-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 653,173 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 934,575 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 76,885 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 636,033 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.34M 2014-06-30 2014 Q2 10-Q 2014-08-07 0001104659-14-058266
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 162,217 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 126,910 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 87,890 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 598.46M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.21M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2.94M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026620
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD -5 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018392
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 166,344 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 38,040 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 101,786 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0001564590-21-055049
us-gaap AreaOfLand Area of Land sqft 4,043 2014-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 5,923 2021-05-05 2022 Q1 10-Q 2022-05-04 0001564590-22-017670
us-gaap Assets Assets USD 98.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AssetsCurrent Assets, Current USD 83.41M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 19.57M 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026055
us-gaap BridgeLoan Bridge Loan USD 1.40M 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares -4.51 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD -57.35M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent USD 7.46M 2013-11-12 2014 Q3 10-Q 2014-11-06 0001564590-14-005169
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 17,027 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 0 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026055
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 225.00M 2014-06-09 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 1.17M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 20.22M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 15.26M 2016-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 20.32M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 20.32M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 19.09M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010484
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -62.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.54M 2014-04-30 2014 Q2 10-Q 2014-08-07 0001104659-14-058266
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 49.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 49.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,984 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 41.18M 2019-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 58,270 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 2.11M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 4.76M 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 1.97M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 6 2014-07-07 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2014-07-07 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 294,876 2015-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -638,400 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 433,998 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -1.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 4.06M 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 1.80M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 7,226 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 3.53M 2016-09-30 2016 Q3 10-Q 2016-11-03 0001564590-16-027150
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 41.18M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018659
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -1.16M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 11.25M 2019-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 99.67M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 20.65M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1.80M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 51.55M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 43,712 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 145,115 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 8.97M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 99.67M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 4.15M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 4.06M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018659
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1,189 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 4,082 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 16,011 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 10,093 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 9,286 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-121063
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 177,230 2014-06-30 2014 Q2 10-Q 2014-08-07 0001104659-14-058266
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -3.46 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-015754
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure -0.15 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 7.60M 2016-09-30 2016 Q3 10-Q 2016-11-03 0001564590-16-027150
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -27.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 27.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -24,785 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -2,651 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap Goodwill Goodwill USD 14.87M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 56.73M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 131,133 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment USD 24.44M 2019-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 56.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 15.20M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -32.11M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.77 2019-10-01 2019-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.17 2020-10-01 2020-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.17 2020-10-01 2020-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 249,485 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 190,228 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 222,002 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 41.18M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -2.55M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -41.18M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 117 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -144,205 2015-01-01 2015-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022499
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -14,808 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -888 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -897,739 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022499
us-gaap IncreaseDecreaseInRegulatoryLiabilities Increase (Decrease) in Regulatory Liabilities USD 3.12M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026055
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 44,986 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 15.20M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap InterestExpense Interest Expense USD 0 2014-07-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001564590-14-005169
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -230,709 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -110,448 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 53,975 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010484
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 92,916 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap InterestPayableCurrent Interest Payable, Current USD 20,508 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 102,632 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 86,774 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap InvestmentsAndCash Investments and Cash USD 133.20M 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 100,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap Liabilities Liabilities USD 184.06M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 98.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.53M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-05 0001564590-15-006132
us-gaap LoansPayableCurrent Loans Payable, Current USD 1.38M 2014-06-30 2014 Q2 10-Q 2014-08-07 0001104659-14-058266
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD -158,263 2015-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 3.49M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 4.94M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.57M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 9.55M 2015-03-31 2015 Q1 10-Q 2015-05-07 0001564590-15-003491
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 3.84M 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap MarketableSecurities Marketable Securities USD 0 2025-12-31 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 56.73M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 5.02M 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -56.93M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 20.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -1.29M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010484
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -55.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 31.32M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010484
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -10.93M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010484
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -34.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -7.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NoncashOrPartNoncashAcquisitionDebtAssumed1 Noncash or Part Noncash Acquisition, Debt Assumed USD 680,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 28,204 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 15.20M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1 Noncash or Part Noncash Acquisition, Other Assets Acquired USD 42,926 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD 681,600 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 321,417 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 5.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap NotesPayableCurrent Notes Payable, Current USD 3.96M 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap OperatingExpenses Operating Expenses USD 36.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -36.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap OperatingLeaseCost Operating Lease, Cost USD 59,970 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0001564590-22-017670
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 111,229 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 111,229 2019-12-31 2020 FY 10-K 2021-03-08 0001564590-21-011340
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 101,786 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 101,786 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006577
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 0 2021-09-30 2021 Q3 10-Q 2021-11-08 0001564590-21-055049
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 100,000 2016-04-01 2016-04-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.22M 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 14,808 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap OtherIncome Other Income USD 26.58M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 28,990 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 389 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 195,195 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 40.66M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 78.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 16,326 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018392
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 6.36M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.30M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.85M 2013-01-01 2013-06-30 2014 Q2 10-Q 2014-08-07 0001104659-14-058266
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 80.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 10.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 28.40M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 22.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 944,683 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 10.00M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009483
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.14M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 11.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -7.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.88M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 195,656 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005224
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 4.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009243
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 195,656 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 17.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 100,000 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026620
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -695.99M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 41.18M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026055
us-gaap Revenues Revenues USD 41.18M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 55.00M 2014-07-06 2014-07-07 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 3.5 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 23,797 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-339171
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2011-12-31 2014 Q3 10-Q 2014-11-06 0001564590-14-005169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 61,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001564590-20-049430
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-121063
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.78 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.84 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015099
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.79 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015099
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.019 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014641
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.02 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015099
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.018 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015099
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.38M 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.30M 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 213,619 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-03 0001564590-16-017361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001564590-21-026731
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 5.2 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 6.60M 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.00M 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.8 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.71 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 8.09 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 8.76 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021615
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -97.52M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 3.5 2014-06-08 2014-06-09 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap StockIssued1 Stock Issued USD 27.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 352,000 2014-07-06 2014-07-07 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 5.34M 2022-06-17 2023 FY 10-K 2024-02-22 0000950170-24-018392
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028509
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 16.54M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 2.65M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 2.11M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 232,534 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002008
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 9.17M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 10.54M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.14M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007853
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 389 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007246
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 5.08M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 10,093 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-13 0001564590-17-004048
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-101117
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 200,000 2016-01-15 2023 Q2 10-Q 2023-08-01 0000950170-23-036159
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 31.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 78.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 5.34M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-015754
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 46.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451797

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →